Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Eur J Endocrinol. 2020 Jul;183(1):63–71. doi: 10.1530/EJE-20-0129

Figure 1. Comparison of traditional and 11-oxyandrogens between patients with nonclassic 21-hydroxylase deficiency (N21OHD) and controls.

Figure 1.

11KT, 11-ketotestosterone; 11OHA4, 11β-hydroxyandrostenedione.